FDA OKs New Kids ' Dose of Cancer Drug

WASHINGTON -- The FDA has approved a pediatric dosage of the cancer drug everolimus (Afinitor Disperz) for the treatment of a rare brain tumor.
Source: MedPage Today Product Alert - Category: Drugs & Pharmacology Source Type: alerts